NordICC The Northern-European Initiative on Colorectal Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Comparison of the screening group vs. the control group in an intention-to-treat model after 15 years of follow-up with regard to CRC mortality and CRC incidence
15 years after screening (interim analysis after 10 years)
No
Hans-Olov Adami, MD PhD
Study Director
Harvard School of Public Health, Boston, USA
Norway: Regional review board
NordICC
NCT00883792
May 2009
July 2036
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
Harvard School of Public Health | Boston, Massachusetts 02115 |